Department of Drug Science, University G. D'Annunzio, Chieti, Italy.
Minerva Med. 2012 Feb;103(1):13-21.
Aim of this study was to evaluate the effects of phytocomplexes of Uncaria, Shiitake and Ribes in terms of viability and inflammatory response on immune cell-derived cultures.
Standardized extracts of Uncaria, Shitake and Ribes and their commercial formulation were tested on cell lines PBMC, U937 and macrophage. The activity was evaluated in terms of cell viability (MTT test), variations of oxidative marker release (ROS and PGE2) and modulatory effects on immune response (gene expression of IL-6, IL-8 and TNFα, RT-PCR).
Cell viability was not affected by extracts, except subtle variations observed only at higher doses (>250 µg/mL). The extract mixture was well tolerated, with no effects on cell viability up to doses of 500 µg/mL. Pre-treatment of macrophages with subtoxic doses of the extracts reduced the basal release of oxidative markers and enhanced the cell response to exogenous oxidant stimulation, as revealed by ROS and PGE2 release reduction. The same treatment on macrophage resulted in a selective modulation of the immune response, as shown by an increase of IL-6 mRNA and, partially, IL-8 mRNA, while a reduction was observed for TNFα mRNA.
Data confirm that extracts and their formulations can act as regulator of the immune system with mechanisms involving the oxidative stress and the release of selected proinflammatory cytokines.
本研究旨在评估钩藤、香菇和黑穗醋栗植物复方在免疫细胞来源的培养物中的生存能力和炎症反应方面的作用。
对 PBMC、U937 和巨噬细胞细胞系进行了钩藤、香菇和黑穗醋栗的标准化提取物及其商业配方的测试。通过细胞活力(MTT 试验)、氧化标记物释放(ROS 和 PGE2)的变化以及对免疫反应的调节作用(IL-6、IL-8 和 TNFα 的基因表达,RT-PCR)来评估活性。
细胞活力不受提取物的影响,除了仅在较高剂量(>250μg/mL)下观察到的细微变化。提取物混合物耐受性良好,在 500μg/mL 以下剂量下对细胞活力没有影响。用亚毒性剂量的提取物预处理巨噬细胞可减少基础氧化标记物的释放,并增强细胞对外源氧化剂刺激的反应,如 ROS 和 PGE2 释放减少所证实的那样。对巨噬细胞的相同处理导致免疫反应的选择性调节,如 IL-6mRNA 的增加,部分 IL-8mRNA 的增加,而 TNFαmRNA 的减少。
数据证实,提取物及其制剂可以作为免疫系统的调节剂,其机制涉及氧化应激和选定促炎细胞因子的释放。